Detalles de la búsqueda
1.
A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients.
Kidney Int
; 103(3): 627-637, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306921
2.
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
Cancer Immunol Immunother
; 70(10): 3015-3030, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34120214
3.
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.
Cancer Immunol Immunother
; 69(8): 1663-1672, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32306076
4.
The doubling potential of T lymphocytes allows clinical-grade production of a bank of genetically modified monoclonal T-cell populations.
Cytotherapy
; 20(3): 436-452, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29396255
5.
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients.
Cancer Immunol Immunother
; 64(7): 805-15, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25846669
6.
[Can academic structures improve access to CAR-T cells?] / Les structures académiques peuvent-elles permettre une amélioration de l'accessibilité aux CAR-T cells ?
Bull Cancer
; 111(1): 62-72, 2024 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-38030508
7.
New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance.
Lab Invest
; 93(10): 1100-14, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23958880
8.
Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy.
J Transl Med
; 9: 63, 2011 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21575188
9.
Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients.
Transplantation
; 105(4): 832-841, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32433241
10.
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients.
Hum Vaccin Immunother
; 17(10): 3511-3514, 2021 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34152898
11.
CICAFAST: comparison of a biological dressing composed of fetal fibroblasts and keratinocytes on a split-thickness skin graft donor site versus a traditional dressing: a randomized controlled trial.
Trials
; 20(1): 612, 2019 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31661012
12.
Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Exp Dermatol
; 17(5): 436-45, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18312383
13.
Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.
J Immunol Res
; 2018: 3530148, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29750176
14.
Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.
J Immunol Methods
; 326(1-2): 63-75, 2007 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-17716681
15.
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.
J Immunother
; 37(3): 170-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24598452
16.
Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy.
PLoS One
; 8(7): e70408, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23894651
17.
Tissue biomarkers in melanoma patients treated with TIL.
PLoS One
; 7(12): e48729, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23284620
18.
Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit".
J Immunol Methods
; 347(1-2): 12-8, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19465023
19.
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.
J Invest Dermatol
; 129(12): 2835-42, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19554023
20.
Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 57(11): 1599-609, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18301889